Bullish, the institutionally focused global digital asset platform that operates Bullish Exchange and owns CoinDesk, saw its shares fall sharply in Friday afternoon trading. BLSH traded at $24.38 as of 3:53 p.m. ET, down $3.10, or 11.28%, from the previous session's close of $27.48. The move reversed most of Thursday's earnings-driven advance, with markets citing cautious analyst actions and a fresh regulatory delay for the tokenization industry as the immediate triggers.
Wall Street's post-earnings review turned more cautious on Friday. Rosenblatt lowered its price target on BLSH to $30.00 from $42.50 and maintained a Neutral rating. JPMorgan separately trimmed its target to $25.00 from $26.00, also with a Neutral stance.
The revisions came despite a strong second-quarter report. Analysts acknowledged that Bullish is diversifying beyond transaction-dependent crypto revenue, but flagged a soft start to third-quarter trading and suggested consensus estimates may need to come down. With the stock still carrying a consensus Hold rating, the downward revisions were enough to trigger selling after a sharp run-up.
Broader regulatory uncertainty compounded the pressure. Reports indicated the SEC was delaying its anticipated "innovation exemption" for tokenized securities and had canceled a meeting on proposed crypto offering rules. The news rippled across tokenization-focused equities, with COIN, CRCL, and FIGR also sliding.
The timing is particularly relevant for Bullish. Earlier this week, the company announced the first tokenized BLSH share trades on its GFSC-regulated exchange, settled against a USD stablecoin, and it is building end-to-end tokenization infrastructure through its pending acquisition of transfer agent Equiniti. A slower regulatory path therefore directly affects the narrative around the company's expansion strategy.
Thursday's session delivered a powerful earnings-driven move, with BLSH climbing roughly 11.6% after adjusted second-quarter results beat expectations. Adjusted revenue rose 62.5% year over year to $92.6 million, and adjusted EBITDA more than tripled to $29.5 million from $8.1 million.
Yet investors had reasons to lock in gains. The company still posted a substantial GAAP net loss tied largely to a Bitcoin markdown, and quarterly trading volume declined to $179.6 billion from $197.4 billion. Once the analyst upgrades-and-target commentary turned cautious, Friday's session became a natural profit-taking event.
BLSH underperformed the broader crypto-equity complex, reflecting company-specific analyst actions on top of sector-wide regulatory pressure. Turnover was active but tracked near or slightly below the stock's typical full-session average of roughly 1.6 million shares.
Technically, the stock broke below the $25.00 level and its 50-day simple moving average near $24.53 during the session. It remains far below its 200-day moving average near $31.92 and its 52-week high of $75.49, while holding above the 52-week low of $20.55.
The near-term outlook hinges on three factors. First, traders will watch whether third-quarter crypto trading volumes stabilize enough to support consensus estimates, or whether more analysts follow Rosenblatt in trimming targets. Second, the SEC's rulemaking timeline for tokenized securities will remain a key sentiment driver. Third, progress toward closing the Equiniti acquisition, expected in January 2027, will shape the company's long-term tokenization infrastructure story. Risks include continued digital-asset price volatility, which can swing both reported earnings and trading activity.
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. The bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a way to explore automated approaches aligned with different market environments. Explore the Trending AI Robots page to see which strategies are currently leading.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BLSH moved above its 50-day moving average on August 13, 2026 date and that indicates a change from a downward trend to an upward trend. In of 4 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 10, 2026. You may want to consider a long position or call options on BLSH as a result. In of 13 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BLSH advanced for three days, in of 39 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLSH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BLSH broke above its upper Bollinger Band on August 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BLSH entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.726) is normal, around the industry mean (25.165). P/E Ratio (0.000) is within average values for comparable stocks, (75.319). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.967). BLSH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.022) is also within normal values, averaging (135.032).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BLSH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows